Cumberland Pharmaceuticals: Sterling Fundamentals Aren’t Enough For A Buy …
Back in 2013, after we wrote a bullish article on Cumberland Pharmaceuticals (NASDAQ:CPIX), a account manager reached out to me. In a successive phone conversation, he asked a doubt (I’m paraphrasing a diction off of memory) that we couldn’t utterly answer: “What are we blank here?” CPIX seemed roughly too good to be true. At […]
Read more »